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Numerous studies have observed cardiac biomarker release
with prolonged exercise. Despite this, we are unsure as to the
constituent aspects of any given exercise bout that may
be important in promoting cardiac biomarker release.
This study examined the influence of exercise duration
and intensity on the appearance of cardiac biomarkers.
Twenty-one subjects ran for 45, 90 and 180min at 85%
and 95% of their individual anaerobic threshold on six
different days randomized. Cardiac troponin I (cTnI) and
N-terminal pro-brain natiuretic peptide (NT-proBNP)
were assayed from blood samples collected before,
30min and 3 h post-exercise. NT-proBNP was elevated
after all exercise trials (range before: 21–32; range
post: 38–67 ng/L). Peak post-exercise concentrations
of NT-proBNP were associated with exercise duration
(P5 0.049), but not exercise intensity (P5 0.451). cTnI
was elevated after all exercise trials (range before: 0.007–
0.011; range post: 0.008–0.021lg/L). Peak post-exercise
concentrations of cTnI were associated with exercise dura-
tion (P5 0.003) and intensity (P5 0.037). Data suggest
that while both cTnI and NT-proBNP increased after all
exercise trials, the mediating effect of duration influenced
both NT-proBNP and cTnI while intensity influenced only
cTnI.
An increasing number of studies have shown that
prolonged strenuous exercise promotes the elevation
of cardiac-specific biomarkers, troponins [cardiac
troponin T (cTnT) and cTnI] and N-terminal pro-
brain natiuretic peptide (NT-proBNP), known to
serologically identify cardiac injury and dysfunction
(Herrmann et al., 2003; Vidotto et al., 2005; Shave et
al., 2007b; La Gerche et al., 2008). As a consequence,
an intense debate has developed over the clinical
repercussions for recreational athletes competing in
long-distance events (Herrmann et al., 2003; Neilan
et al., 2006; La Gerche et al., 2008). While most
scientific literature has reported that cardiac biomar-
kers decrease to normal levels in the days following a
competition (Herrmann et al., 2003; La Gerche et al.,
2008), suggestive of a physiological response (Schar-
hag et al., 2005, 2006), three recent studies have
shown an association between the increase in cardiac
biomarkers and echocardiographic evidence of a
reduction in cardiac function following completion
of a marathon (Neilan et al., 2006) or an ultra-
endurance triathlon (Tulloh et al., 2006; La Gerche
et al. 2008).
The awareness, and clinical interpretation, of ex-
ercise-related changes in cardiac-specific biomarkers
is complicated by high inter-individual variation in
available field-based competitive data (Shave et al.,
2007b) that may be partially explained by large
variations in exercise parameters such as duration
and intensity. Field-based competitive studies are
normally based on set distance courses (marathon,
triathlon) and as such exercise duration and intensity
are highly variable. On this basis, the influence, for
example, of exercise duration on cardiac-specific
biomarker release is poorly understood and contro-
versial. Neilan et al. (2006) found that those runners
with lower training experience showed the greatest
increase in cTnT following a marathon race. Never-
theless, the authors did not report the correlation
level between exercise duration and cTnT release. In
contrast, Rifai et al. (1999) observed a significant
inverse correlation between the race time in an Iron-
man event and post-race cTnT. In other individual
competitions, exercise duration has not been asso-
ciated with increases in cTnI or cTnT (Scharhag et
al., 2005, 2006; George et al., 2004) but recently, a
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meta-analysis reported that post-exercise cTnT va-
lues decreased slightly as the event duration in-
creased (Shave et al., 2007b), which was speculated
to be related to lower exercise intensities in ultra-
endurance events. Researches assessing cardiac-spe-
cific biomarkers in association the manipulation of
exercise intensity and duration are not available.
While the clinical significance of the increase in
cardiac-specific biomarkers following strenuous en-
durance exercise in healthy athletes is unclear, the
importance and role of factors that may promote




Twenty-one runners, 19 males (age: 38  8 years; height:
1.77  0.07m; body mass: 73.6  6.3 kg; VO2max: 58.0 
5.1mL/kg/min; training history: 11  8 years, training volume:
75  35km/week) and two females (age: 38.5  0.7 years;
height: 1.55  0.06m; body mass: 52.7  6.2 kg; VO2max:
49.3  3.9mL/kg/min; training history: 8  4 years, training
volume: 48  18km/week), scheduled to participate in the
2008 Zaragoza marathon race, were recruited by an open
invitation linked to the official web page for the race organiza-
tion. After an initial meeting, where the aim and protocol of
the research were explained, all subjects provided written
informed consent. The study was approved by the Research
Ethics Committee of the Government of Aragón (Spain).
To exclude acute or chronic diseases, an initial medical
examination including recording the history of cardiac symp-
toms, resting blood pressure, electrocardiography and stan-
dard echocardiography was performed. In addition, a
functional test for the determination of the maximum oxygen
uptake (VO2max) and parameters corresponding to the indivi-
dual anaerobic threshold (IAT) was performed.
On 6 days separated by 1 week, and in a randomized order,
athletes performed exercise trials of 45-, 90- and 180-min
duration at intensities of 85% and 95% IAT on a natural
circuit (distance: 4600m, maximum slope: 2%). An intensity
of 95% IAT was chosen as a representation of the maximal
sustainable intensity for 3 h of exercise, and an intensity of
85% IAT as a submaximal intensity for each duration that
would be completed at an heart rate (HR) significantly lower
than the 95% IAT trial. This may be more akin to a training
run. Intensities were determined by HRs and checked by HR
monitoring of the submaximal bouts (Polar, Kempele, Fin-
land). A maximum variation of  2 beats/min was allowed
between the prescribed HR and the actual measured value.
Venous blood samples to measure cardiac biomarkers were
taken before, 30min and 3 h after each exercise. Runners were
advised to avoid strenuous exercise 2 days before each trial.
All trials took place between May and June, with small
variations in temperature (16.8  2.0 1C) and humidity
(67.7  10.0%).
Exercise ergometry
To determine the IAT using the method of Stegmann et al.
(1981), incremental multistage treadmill ergometry (Laufer-
gotest, Jaeger, Germany) was started at 8 km/h, and increased
by 2 km/h every 3min until exhaustion. Capillary blood
samples were taken from the hyperaemized earlobe at the
end of each stage and 1, 3, 5, 7, 10 and 20min after cessation
of exercise to determine lactate concentrations (1500 sport
YSI, Yellow Springs, Ohio, USA). In addition, a 12-lead
ECG, blood pressure and VO2 (CPX/MAX MedGraphics,
St. Paul, Minnesota, USA) were recorded.
Cardiac-specific biomarkers
Before and after all prolonged exercise trials, blood samples
were drawn from an antecubital vein and collected in tubes.
Samples were quickly centrifuged and the plasma was stored
below  80 1C. NT-proBNP was measured by chemilumines-
cence on an automated analyzer (Elecsys proBNP; Elecsys
2010; Roche Diagnostics, Mannhein, Germany). The URL for
NT-proBNP was considered to be 125 ng/L (Al-Barjas et al.,
2004). cTnI was measured by chemiluminescence inmunoas-
says on automated analyzers (AccuTnI, Access; Beckman
Coulter, Krefeld, Germany). The URL for cTnI, defined as
the 99th percentile of healthy participants, was 0.04 mg/L
(Apple et al., 2003).
Statistical analysis
Statistical analyses were performed using the Statistical Pack-
age of Social Sciences, version 15.0. Data are expressed as
means with the corresponding standard deviations. Initially,
to also assess the impact of measurement time (pre, 30min and
3 h post), a repeated-measures three-way analysis of variance
(ANOVA) was run on NT-proBNP and cTnI data. Conse-
quently, two-way ANOVAs (duration and intensity) were
performed on peak post-exercise concentrations of NT-
proBNP and cTnI data as well as exercise HR and distance
covered. Post hoc Tukey tests were used where appropriate. In
order to observe the presence of significance differences among
the exercise trials in the percentage of subjects with post-
exercise cardiac biomarkers values that exceeded the URL, a
comparison of the proportions was performed using a chi-
squared analysis. A multivariate linear regression was used to
assess the relationships between the absolute and the relative
exercise-related increase in cardiac biomarkers as dependent
variables and baseline biomarker data, age, VO2max and
velocity at IAT as the independent predictors.
Results
IAT test data, HR and distance covered
The IAT was identified at 12.7  1.8 km/h, HR:
155  8 beats/min, %HRmax: 85  6, %VO2max:
77  10. HR at 95% and 85% of the IAT was
established as 147  7 beats/min (82  3%HRmax)
and 132  6 beats/min (73  3%HRmax), respec-
tively. All runners were able to complete all exercise
trials at the prescribed intensities. For HR during
exercise (see Table 1), there was no significant effect
of duration or a duration  intensity interaction
(P40.05). As would be expected, HR was signifi-
cantly altered by exercise intensity (P5 0.000). For
distance covered during each exercise trial (Table 1),
there was, as expected, a significant effect of duration




NT-proBNP and exercise duration and intensity
Pre-exercise values of NT-proBNP were not signifi-
cantly different for all trials. From the three-way
ANOVA, a significant main effect of assessment time
(pre: 25.76 ng/L; post 30min: 51.59 ng/L; post 3 h:
51.14 ng/L; P5 0.000) confirmed an exercise re-
sponse (Table 2). Analysis of peak responses post-
exercise detailed a significant main effect for duration
of trail (P5 0.049) but no main effect of intensity
(P5 0.451) or interaction (P5 0.810). Pre-exercise
values NT-proBNP were below the URL of 125 ng/L
in all participants. Post-exercise, there were no sig-
nificant differences among the exercise trials in the
percentage of subjects who exceeded the URL
(range: 5–14%). The exercise-related increases in
NT-proBNP were independent of the age, training
status, VO2max and the other variables controlled in
the study. In all exercise trials, the resting values of
NT-proBNP were significantly correlated (Fig. 1)
with the absolute post-exercise values (r5 0.87–
0.96, P5 0.000) as well as with relative changes
with exercise (r5 0.65–0.80, P5 0.000).
cTnI and exercise duration and intensity
Pre-exercise values of cTnI were not significantly
different for all trials. From the three-way ANOVA,
a significant main effect of assessment time (pre:
0.008; post 30min: 0.011; post 3 h: 0.013 mg/L;
P5 0.000) confirmed an exercise response (Table
3). Analysis of peak responses post-exercise detailed
significant main effects for duration (P5 0.003) and
intensity (P5 0.037) of trial but no interaction
(P5 0.574). All pre-exercise cTnI concentrations
were below the URL, with the exception of one
subject, who was slightly above the URL on two
days. Post-exercise, there were no significant differ-
ences among the exercise trials in the percentage of
subjects who exceeded the URL of cTnI (range: 0–
9%). The exercise-related increases in cTnI were
independent of the age, training status, VO2max and
the other variables controlled in the study. In all
exercise trials, the resting values of cTnI were sig-
nificantly correlated with the post-exercise values
(r5 0.45–0.86, Po0.05) (Fig. 2), but were not asso-
ciated with the delta change scores.
Discussion
This study demonstrates, for the first time, by con-
trolled manipulation in the same cohort of endurance
runners, the influence of exercise duration and in-
tensity on post-exercise elevations in cardiac-specific
biomarkers. The key finding was that exercise dura-
tion has a mediating effect on peak post-exercise
concentrations of NT-proBNP and cTnI, whereas
exercise intensity significantly influences only cTnI.
Table 1. Mean exercise HR and distances covered in the exercise trials
HR (beats/min) Distance covered (km)
85% IAT 95% IAT 85% IAT 95% IAT
45 min 132  7 147  8* 8.0  1.1# 9.4  1.1*#
90 min 132  6 147  7* 15.5  2.3# 18.1  2.1*#
180 min 133  7 147  7* 30.0  3.7# 34.8  4.2*#
*Significantly different from other exercise intensity.
#Significantly different from other exercise duration.
IAT, individual anaerobic threshold; HR, heart rate.
Table 2. NT-proBNP levels (ng/L) before and after the exercise trials
85% IAT 95% IAT
Pre-exercise 30 min post 3 h post Pre-exercise 30 min post 3 h post
45 min 27  26 38  42 43  47 32  31 43  46 46  46
90 min 25  29 42  38 45  41 28  27 52  39 51  37
180 min 23  25 67  57 63  54 21  17 65  63 58  46
Significant main effect for exercise duration but no significant interaction.

































10 20 30 40 50 60 70
Fig. 1. Correlation between pre-exercise and post-exercise
levels of N-terminal pro-brain natiuretic peptide (NT-
proBNP) in a running trial of 180min at 95% individual
anaerobic threshold.
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An increase in the post-exercise NT-proBNP con-
centration with longer exercise bouts is not surprising
when one considers that physiologically and patho-
logically BNP is elevated in response to volume
overload and myocyte stretch (Shave et al., 2007a).
Indirect support for the impact of exercise duration
comes from data produced in ultra-endurance studies
such that NT-proBNP concentrations after 180min
of running at 95% IAT were smaller than concentra-
tions observed after a 230 km cycle race (Neumayr et
al., 2005). Despite higher NT-proBNP values after
the exercise trials at 95% IAT, these differences were
not significant compared with the 85% IAT trial.
This may reflect the small absolute and relative
difference in exercise load between these two inten-
sities. With a high inter-individual response to ex-
ercise (Neumayr et al., 2005), the small increase in
ventricular load or stretch in the current design may
be statistically underpowered to detect small differ-
ences. Again, of interest is the fact that values of the
post-exercise cardiac biomarkers observed in the 90-
and 180-min trials at 95% IAT were lower than the
concentrations reported for competitive events such
as the 21 km race (Vidotto et al., 2005; Tian et al.,
2006) and a marathon (Neilan et al., 2006; Shave et
al., 2007b), which, although could be influenced
partially by a greater training status in our runners,
may suggest that 95% IAT underestimates the actual
competitive running speed. Indeed, from within our
own cohort, we have evidence from HR data col-
lected during competitive running events that 95%
IAT underpredicted maximal sustainable running
HR in these athletes by 20 beats/min in a 21 km
race and by 13 beats/min in a marathon race. Thus,
despite a lack of statistically significant difference in
NT-proBNP data between running at 85% and 95%
IAT, it would be too presumptive, at this stage, to
suggest there is no broad effect of exercise intensity
on this biomarker.
The fact that the cTnI values were increased in the
longer as well as in the more intense bouts of exercise
again likely reflects an impact of exercise volume and
cardiac work. No previous studies have assessed cTn
reponses in the same runners while systematically
varying exercise duration and intensity but a recent
meta-analysis (Shave et al., 2007b) reported that the
occurrence of ‘‘positive’’ cTnT assays after pro-
longed exercise was mediated by exercise duration,
with fewer responders after ultraendurance exercise
(e.g. Ironman) compared with shorter endurance
events (e.g. Marathons). These authors speculated
that this could reflect a reduced exercise intensity
sustained over more prolonged competitive events.
Roth et al. (2007) further found no cTnT-positive
rate in seven adult runners after a 216 km ultraen-
durance marathon on run. The negative effect of
exercise duration on cTnT release was postulated as a
result of the corresponding reduction in the exercise
intensity and the resultant low stress placed on the
cardiovascular system (Scharhag et al. 2008). This
serves to indicate some of the problems in delineating
the effects of exercise duration and intensity on
responses seen in competitive running. It is pertinent
to note that cTnI was also elevated from baseline
after a shorter less intense exercise that may actually
fit with our recent case-study finding of elevated cTnI
after walking exercise (unpublished observations).
The significant impact of exercise intensity on peak
post-run cTnI in the current study may coincide with
the increased level of free radicals that others have
speculated may be involved in the mechanism of cTn
release from cardiomyocytes post-exercise (Shave
Table 3. cTnI (mg/L) levels before and after the exercise trials
85% IAT 95% IAT
Pre-exercise 30 min post 3 h post Pre-exercise 30 min post 3 h post
45 min 0.007  0.01 0.008  0.01 0.009  0.01 0.007  0.01 0.008  0.01 0.010  0.01
90 min 0.009  0.01 0.010  0.01 0.009  0.01 0.007  0.01 0.008  0.01 0.016  0.02
180 min 0.008  0.01 0.012  0.01 0.011  0.01 0.011  0.01 0.017  0.02 0.021  0.02
Significant main effect for exercise duration and intensity but no significant interaction.
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Fig. 2. Correlation between pre-exercise and post-exercise
levels of cardiac troponin I (cTnI) in a running trial of
180min at 95% individual anaerobic threshold.
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et al., 2007b). At present, this theory has no sub-
stantive evidence to support it but is worthy of an on-
going investigation.
Although we do not fully understand the physiolo-
gical and/or the clinical impact of the cardiac-specific
biomarker changes after prolonged exercise, the cur-
rent data (in absolute and URL terms) suggest a minor
and possibly physiological perturbation. With implica-
tions for the acute care management of endurance
athletes, it is pertinent to note that only a relatively
small percentage of runners demonstrated either NT-
proBNP or cTnI increases beyond their respective
URL even in the exercise trial of the greatest duration
and intensity (o15%), although the current data may
underpredict biomarker values seen after competitive
events (Vidotto et al., 2005; Neilan et al., 2006; Tian et
al., 2006; Shave et al., 2007b). A technical reason for
the low biomarker concentrations and limited data
exceeding URLs may relate to the frequency of blood
sampling during and post-exercise (Middleton et al.,
2008). Recently, Middleton et al. (2008) were the first
to assay cTnT repeatedly during a laboratory tread-
mill-based marathon and multiple samples over the
first 24h of recovery. Interestingly, with a greater
sampling frequency, this paper reported an elevation
of cTnT in all subjects and thus it is clear that fewer
samples would likely increase the chance of missing
‘‘true’’ peak concentrations and data exceeding URLs.
Future work should attempt to replicate this finding
and determine whether this response is mediated by
subject- and exercise-related factors. The hypothetical
model proposed by Whyte (2008), suggesting that a
limit exists in the exercise duration and/or the intensity
that determines the point of inflexion of the healthful
or harmful effects of the physical activity on the heart,
is interesting but remains unsupported by the current
data. Our results suggest, like others (Middleton et al.,
2008), that the increase in cardiac biomarkers is
probably inherent to the physical activity, but that
their magnitude is low or insignificant if the exercise
intensity and duration are moderate.
It is interesting that the only factor that signifi-
cantly predicted post-exercise values of NT-proBNP
or cTnI was their respective pre-exercise values.
Specifically, our results confirm for the NT-proBNP
values those observed by Sahlén et al. (2008), and
indicate for the first time, for the cTnI values, that
exercise in runners with greater resting values in-
duced a greater absolute increase in cardiac-specific
biomarkers. This has been suggested previously for
NT-proBNP, with possible mediation via increased
age (Neumayr et al., 2005), although age was not a
significant predictor in the current study. Given that
the resting NT-proBNP data demonstrated high
reproducibility even after a 3-year period (Sahlén et
al., 2008), these results suggest a more complex
interaction of baseline, prior exercise and exercise-
related factors that mediate cardiac biomarker re-
sponses to prolonged exercise. In the general popula-
tion, the baseline NT-proBNP value is influenced by
age and sex (Olsen et al., 2008) while in recreational
athletes, greater NT-proBNP levels at baseline have
been associated weakly with increased LV mass index
(Sahlén et al., 2008) and with age (König et al., 2003).
Further exploratory research in a broad range of
normal and athletic groups is suggested. In a similar
way, this study demonstrated that the post-exercise
levels of cTnI were associated with the baseline
concentrations. As with NT-proBNP, these results
suggest the importance of understanding what fac-
tors are associated with baseline levels of cTnI.
Specifically, further analysis with highly sensitive
assays in a broad range of normal and athletic
populations would be useful.
The influence of gender on exercise-related
changes in cardiac-specific biomarkers is an interest-
ing point that is not clear at present. This aspect
could not be addressed in our study due to the fact
that only two female runners were recruited. There-
fore, it cannot be excluded that the relationship
between exercise duration and intensity on the ap-
pearance of cardiac biomarkers as well as its kinetic
could be influenced by the gender.
In conclusion, the results of this study indicate that
an exercise-induced increase in NT-proBNP is influ-
enced more by exercise duration than intensity, while
changes in cTnI are mediated by both in endurance-
trained runners. The percentage of cases demonstrat-
ing post-exercise NT-proBNP and cTnI levels above
their respective URLs was low, probably because the
exercise volume in this repeated measures study was
moderate. Further work looking at cTn appearance
using the standard exercise prescription in healthy
subjects and in cardiac patients may be useful.
Perspectives
In this study, we highlighted that exercise duration
and intensity are factors associated with the release
of cardiac biomarkers. These results are important
to inform and educate those who may measure cTn
in subjects who have performed recent bouts of
physical exertion. Future work may develop this
area by investigating cTn release and exercise (pos-
sibly influenced by duration and intensity) in healthy
subjects and cardiac patients. Finally, this investi-
gation prompts further research into the factors
associated with the inter-subject variability in the
baseline and exercise-related values of NT-proBNP
and cTnI.
Key words: troponin I, NTpro-BNP, exercise dura-
tion, exercise intensity.
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